Mohn Cancer Research Laboratory (MCRL) was established in 2009 at the Laboratory Building at Haukeland University Hospital campus by Bergen Medical Research Foundation (BMFS) and Trond Mohn
The main focus of our research is to identify the genetic and molecular mechanisms that influence the risk of various types of cancer, as well as the mechanisms that have impact on treatment results of cancer patients.
Researchers at the laboratory work with the following issues:
● Somatic mutations that make cancer cells resistant to treatment.
● Germline factors that influence the risk of cancer and result in different clinical expressions and different degrees of side effects during treatment.
● Hormones and their role in cancer development and treatment of various hormone-sensitive cancers.
Research is mainly focused on cancer arising in the breast, ovaries, testes, prostate and the gastrointestinal tract as well as on malignant melanomas.
Mohn Cancer Research Laboratory is a modern facility, fully equipped with state of the art technology for translational cancer research, including an in-house massive parallel sequencing facility, cell culture facilities and infrastructure for all types of molecular analyses.
MCRL has scalable, dedicated servers and storage domains directly linked to our in-house sequencing infrastructure, within the frameworks of the IT-departments at the University of Bergen and Haukeland University Hospital.